A Post Marketing Surveillance (PMS) strategy will soon be implemented to test the quality of medicines in the region.
In fact, it was discussed at a two-day meeting hosted by the Caribbean Public Health Agency (CARPHA), in Jamaica.
That country’s Health Minister Dr Christopher Tufton says the strategy will combat against increased findings of substandard and falsified medicines around the world.
He explains that once tests are done, the results will be given to regulatory authorities to evaluate and make decisions on the quality of products used in their respective countries.
Dr Tufton however says the strategy’s success is dependent on adequate resources and collaboration among all stakeholders.